GTTAC was provided a draft consultation RARMP prepared by the Regulator which concluded that the proposed release poses negligible risks to the health and safety of people and the environment as a result of gene technology. Advice was sought by the Regulator from GTTAC on the following issues: Does the risk assessment identify all plausible risk scenarios by which the proposed release could give rise to risks to the health and safety of people or the environment? Are the measures to limit and control the release appropriate for the trial? Is there any additional key information that should be considered? Does the committee agree with the overall conclusions of the RARMP? GTTAC discussed the potential for allergenicity to the pectin methylesterase proteins (PME) expressed in the GMOs and the effectiveness of proposed personal protective equipment for individuals working with the GMO during processing to limit contact or inhalation of PMEs. GTTAC advised the Regulator that: RESOLUTION – INFORMATION ITEMS AND REPORTS GTTAC received a report from the acting Regulator that provided updates on activities undertaken by the Regulator and the OGTR since the previous GTTAC meeting (April 2015). Enquiries and Risk Assessment and Risk Management Plans For all enquiries and to obtain copies of applications or RARMPs for dealings involving the intentional release of GMOs into the environment, please phone the OGTR on 1800 181 030. RARMPs are also available electronically from the OGTR website at <http://www.ogtr.gov.au>. GLOSSARY This section contains a brief description of terms relevant to an understanding of this quarterly report. They do not substitute for definitions of terms relevant to the operation of the gene technology regulatory system that are contained in section 10 of the Gene Technology Act 2000. Accredited organisation An organisation that is accredited under section 92 of the Act Act Gene Technology Act 2000 Breach of a licence condition A breach of a licence condition which has been proven either in court or by way of admission following investigation
GTTAC was provided a draft consultation RARMP prepared by the Regulator which concluded that the proposed release poses negligible risks to the health and safety of people and the environment as a result of gene technology. Advice was sought by the Regulator from GTTAC on the following issues: Does the risk assessment identify all plausible risk scenarios by which the proposed release could give rise to risks to the health and safety of people or the environment? Are the measures to limit and control the release appropriate for the trial? Is there any additional key information that should be considered? Does the committee agree with the overall conclusions of the RARMP? GTTAC discussed the potential for allergenicity to the pectin methylesterase proteins (PME) expressed in the GMOs and the effectiveness of proposed personal protective equipment for individuals working with the GMO during processing to limit contact or inhalation of PMEs. RESOLUTION – GTTAC advised the Regulator that: INFORMATION ITEMS AND REPORTS GTTAC received a report from the acting Regulator that provided updates on activities undertaken by the Regulator and the OGTR since the previous GTTAC meeting (April 2015). Enquiries and Risk Assessment and Risk Management Plans For all enquiries and to obtain copies of applications or RARMPs for dealings involving the intentional release of GMOs into the environment, please phone the OGTR on 1800 181 030. RARMPs are also available electronically from the OGTR website at <http://www.ogtr.gov.au>. GLOSSARY This section contains a brief description of terms relevant to an understanding of this quarterly report. They do not substitute for definitions of terms relevant to the operation of the gene technology regulatory system that are contained in section 10 of the Gene Technology Act 2000. Accredited organisation An organisation that is accredited under section 92 of the Act Act Gene Technology Act 2000 Breach of a licence condition A breach of a licence condition which has been proven either in court or by way of admission following investigation
qrptSep2015.docx